Poliomyelitis
Poliomyelitis, usually called polio, is an infection caused by poliovirus. Most infections do not cause obvious illness, but some lead to fever, headache, vomiting, neck stiffness, limb pain, and, in a small share of infections, paralysis. WHO says paralysis occurs in about 1 in 200 infections, and 5% to 10% of people with paralytic polio die when the breathing muscles are affected. The virus spreads mainly by the fecal-oral route, meaning virus from stool reaches another person through contaminated hands, water, food, or surfaces. WHO says the incubation period is usually 7 to 10 days, with a range of 4 to 35 days. There is no cure that removes the virus, so care is supportive, but vaccination can prevent the disease. Wild poliovirus type 1 still circulates in a small number of places, while vaccine-derived polioviruses can cause outbreaks where population immunity is low. WHO continues to treat international poliovirus spread as a serious cross-border risk.
Key facts
| Transmission | Person to person, mainly by the fecal-oral route; less often through contaminated water or food. |
|---|---|
| Incubation | Usually 7–10 days; range 4–35 days. |
| Case fatality | Approximately 5%–10% among paralytic cases, according to WHO; most infections are not paralytic. |
| Reproduction number | unknown |
| Vaccine | Yes. Polio vaccines are available, including inactivated polio vaccine (IPV) and oral polio vaccines used in outbreak response and some programmes. |
| Treatment | No cure for polio; treatment is supportive. |
| Reservoir | Humans. |
| Endemic regions | Wild poliovirus type 1 remains endemic in Afghanistan and Pakistan; vaccine-derived polioviruses have caused outbreaks in multiple countries in Africa, Asia, the Middle East, Europe and the Pacific when immunity is low. |
Transmission
Polio spreads from person to person. WHO says the main route is fecal-oral transmission. In plain terms, virus from an infected person’s stool can reach another person through unclean hands, contaminated water, food, or surfaces. WHO also notes that common vehicles such as contaminated water or food can spread it, though this is less emphasized than direct fecal-oral spread. After infection, the virus multiplies in the intestine. Most infected people have no symptoms or only mild illness, so spread can continue unnoticed. WHO says up to 90% of infected people are asymptomatic or have only mild symptoms. That makes surveillance important, because paralysis is only the visible tip of transmission. Vaccine-derived polioviruses can also spread in under-immunized communities after the weakened virus used in oral vaccine changes over time during person-to-person circulation.
Symptoms and severity
Polio often causes no clear illness, but when symptoms happen they usually start with fever, fatigue, headache, vomiting, neck stiffness, and pain in the limbs. WHO says the incubation period is usually 7 to 10 days, but it can range from 4 to 35 days. A small proportion of infections affect the nervous system and cause paralysis. WHO gives a rough severity figure of about 1 paralytic case for every 200 infections. Paralysis is often permanent. The most serious danger is when the muscles used for breathing are affected. WHO says 5% to 10% of people with paralytic polio die in those severe cases. The disease largely affects children under 5 years of age, but it is not limited to them. Because most infections are silent, finding poliovirus in sewage or in healthy contacts can still signal a real outbreak risk.
- Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America WHO · 14 Sept 2022
- Polio Wikipedia
Treatment and vaccines
There is no cure that clears poliovirus once infection is established. WHO states this directly: polio can be prevented by immunization, but not cured. Care for sick patients is therefore supportive. That can include help with breathing, fluids and nutrition, pain control, and rehabilitation for weakness or paralysis. Prevention is the main tool. WHO outbreak reports describe use of inactivated polio vaccine, or IPV, in routine schedules, and oral polio vaccine products in outbreak response. Which vaccine is used depends on the setting and the poliovirus type involved. Vaccine-derived outbreaks do not mean vaccines have failed in a simple sense; WHO explains they arise when weakened oral vaccine virus keeps circulating long enough in under-immunized communities to change genetically. High routine coverage and fast outbreak vaccination campaigns are what stop both wild and vaccine-derived poliovirus spread.
- Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America WHO · 14 Sept 2022
- Circulating vaccine-derived poliovirus type 1- Israel WHO · 20 Aug 2025
- Circulating vaccine-derived poliovirus type 2 (cVDPV2) - Papua New Guinea WHO · 20 May 2025
Where it occurs
Polio has not been eliminated everywhere. WHO’s recent outbreak notices show two different patterns. First, wild poliovirus type 1 still appears in a small number of places, with recent WHO notices in past years linked to Malawi and Mozambique after importation, while ongoing concern remains centered on Afghanistan and Pakistan. Second, circulating vaccine-derived polioviruses, especially type 2, have been detected across many regions when immunity gaps allow spread. Recent WHO notices in the archive include Indonesia, Kenya, Tanzania, Burundi, Sudan, Papua New Guinea, Israel, the United Kingdom, the United States, and others. Some detections are from sewage or healthy children rather than paralytic cases, but WHO treats them seriously because they show community transmission. In practice, polio risk is highest where vaccination coverage is patchy, surveillance is weak, sanitation is poor, or large mobile and under-served populations are present.
- Circulating vaccine-derived poliovirus type 1- Israel WHO · 20 Aug 2025
- Circulating vaccine-derived poliovirus type 2 (cVDPV2) - Papua New Guinea WHO · 20 May 2025
- Circulating vaccine-derived poliovirus type 2 - Indonesia WHO · 11 Jan 2024
- Circulating vaccine-derived poliovirus type 2 – Kenya WHO · 28 Jul 2023
Recent history
This site’s archive lists 87 polio-related events since 1996, showing that polio remains a long-running international public-health problem even after huge global progress. WHO’s recent Disease Outbreak News items show repeated cVDPV2 events in 2022 to 2025, including Indonesia, Sudan, Burundi, Kenya, Tanzania, Papua New Guinea, and environmental detections linked across Israel, the United Kingdom, and the United States. WHO also says the international spread of poliovirus has remained under a Public Health Emergency of International Concern framework since 2014, and that this status was extended again in 2025. The pattern in the archive is important: many events are not large visible epidemics, but single paralytic cases, sewage detections, or virus found in healthy children. That tells readers something simple but important: with polio, one confirmed detection can matter because it may point to wider hidden transmission.
- Circulating vaccine-derived poliovirus type 1- Israel WHO Disease Outbreak News · 20 Aug 2025
- Circulating vaccine-derived poliovirus type 2 (cVDPV2) - Papua New Guinea WHO Disease Outbreak News · 20 May 2025
- Circulating vaccine-derived poliovirus type 2 - Indonesia WHO Disease Outbreak News · 11 Jan 2024
- Circulating vaccine-derived poliovirus type 2 – United Republic of Tanzania WHO Disease Outbreak News · 28 Jul 2023
What to watch
The main warning signs are not mysterious. First, any new detection in a place that has been polio-free, especially in sewage, a child with acute flaccid paralysis, or healthy contacts, deserves attention. Second, spread across borders matters; WHO repeatedly flags international movement and linked viruses in neighboring countries as a major risk. Third, falling vaccination coverage is a clear danger signal, because low immunity is what allows both wild poliovirus and vaccine-derived polioviruses to circulate. Fourth, weak surveillance can hide spread until paralysis appears, which is late. Fifth, vaccine supply or campaign delays matter, especially during conflict, displacement, or distrust of vaccination. Finally, any evidence of sustained community transmission in new regions would make the situation more concerning. WHO’s recent notices make a consistent point: as long as poliovirus exists anywhere, under-immunized communities everywhere remain at risk.
- Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America WHO · 14 Sept 2022
- Circulating vaccine-derived poliovirus type 2 (cVDPV2) - Papua New Guinea WHO · 20 May 2025
- Circulating vaccine-derived poliovirus type 1- Israel WHO · 20 Aug 2025
- Circulating vaccine-derived poliovirus type 2 – Kenya WHO · 28 Jul 2023
Related outbreaks
- Poliovirus (wild and vaccine-derived) Attention: elevated
- Polio outbreak in Khyber Pakhtunkhwa, Pakistan elevated